[ad_1]
Convention Name Individuals
Richard Vosser – JPMorgan Chase & Co, Analysis Division
Presentation
Richard Vosser
JPMorgan Chase & Co, Analysis Division
Welcome to the JPMorgan Healthcare Convention. I am Richard Vosser, European pharma analyst for JPmorgan. It is my nice pleasure to introduce Sanofi. From the convention we’ve got 3 of the very senior administration right here to entertain us now. Paul Hudson, CEO; François-Xavier Roger, CFO; and Houman Ashrafian.
Paul Hudson
CEO & Director
You absolutely butchered each title.
Richard Vosser
JPMorgan Chase & Co, Analysis Division
Each title, yearly.
Paul Hudson
CEO & Director
Yearly.
Richard Vosser
JPMorgan Chase & Co, Analysis Division
It is constant, however that is what we like. So I higher shut up then and hand to Paul for a couple of introductory remarks, after which we will chat collectively.
Paul Hudson
CEO & Director
Thanks, Mr. Vosser. We respect that.
Richard Vosser
JPMorgan Chase & Co, Analysis Division
That was unsuitable, Paul.
Paul Hudson
CEO & Director
Nice — we solely have a handful of slides, however I will simply — we’ll put a — I’ve 1, Houman has a pair. Thanks for making the time. It has been an especially busy yr final yr for us, and we had a few challenges in R&D, which I feel are nicely communicated. We additionally made a vital industrial progress. We have been rising 8.7% by way of Q3. Script traits, in the event that they keep constant by way of the rest of the yr throughout the main drivers of that, we will be near double-digit progress. That double-digit progress profile we predict we are able to preserve for the subsequent half decade plus. And that places us in fairly a uncommon group
[ad_2]
